Status:
UNKNOWN
THRIVE Apneic Ventilation With Standardized Airway Management During General Anesthesia.
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Apnea
Ventilation Therapy; Complications
Eligibility:
All Genders
18+ years
Brief Summary
Transnasal Humidified Rapid-Insufflation Ventilatory Exchange (THRIVE) denotes the use of high-flow humidified nasal oxygen system (for example Optiflow®) as an alternative ventilation modality for an...
Detailed Description
THRIVE is previously shown feasible as sole mode of ventilation in selected patients during general anaesthesia for minor laryngeal surgery for a limited time up to 30 minutes, where direct laryngosco...
Eligibility Criteria
Inclusion
- Adult (age over 18 years)
- Elective surgery where intubation is not mandatory
- The patient can understand the information about the study and give their informed written consent of participation
Exclusion
- ASA (American Society of Anaesthesiologists class) \> 3
- NYHA (New York Heart Association class) \> 2
- BMI \> 30 kg/m2
- Symptomatic respiratory disease
- Symptomatic cardiac disease
- Evidence of arteriosclerotic disease
- Neuromuscular disease
- Pregnancy
- Presumed or predicted difficult airway (SARI - Simplified Airway Risk Index score \> 4)
- Known or suspected nasal congestion/stenosis or catharalia
Key Trial Info
Start Date :
January 8 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2019
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT03797859
Start Date
January 8 2019
End Date
June 1 2019
Last Update
January 23 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet
Copenhagen, Hoevdstaden, Denmark, 2100
2
Rigshospitalet, section for anaesthesia for ENT and Maxillofacial surgery, section 3071
Copenhagen, Denmark, 2100